synuclein beta
| GO Term | Evidence Code | PMID |
|---|---|---|
| chemical synaptic transmission | ||
| dopamine metabolic process |
|
|
| negative regulation of neuron apoptotic process |
|
|
| synaptic vesicle endocytosis | ||
| synaptic vesicle endocytosis |
| GO Term | Evidence Code | PMID |
|---|---|---|
| cytoplasm | ||
| cytoplasm | ||
| cytosol | ||
| inclusion body | ||
| inclusion body |
| GO Term | Evidence Code | PMID |
|---|---|---|
| phospholipase inhibitor activity | ||
| calcium ion binding | ||
| protein binding | ||
| transition metal ion binding | ||
| cuprous ion binding |
| Gene Ontology |
|---|
| chemical synaptic transmission |
| cuprous ion binding |
| synapse organization |
| InterPro |
|---|
| Beta-synuclein |
| Synuclein |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:12217 | Lewy body dementia | |
| DOID:14330 | Parkinson's disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026